ArticleBMC cancer2021

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types.

Sojung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.